A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease
Despite the ubiquity of the Boston naming test (BNT) in clinical practice and research, concerns have been expressed about its poor quality pictures, insufficient psychometric properties, and cultural bias in non-English language backgrounds. We modified the black-and-white BNT with a set of color p...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-04-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.884460/full |
| _version_ | 1818522397702094848 |
|---|---|
| author | Dan Li Yue-Yi Yu Nan Hu Min Zhang Li Liu Li-Mei Fan Shi-Shuang Ruan Fen Wang |
| author_facet | Dan Li Yue-Yi Yu Nan Hu Min Zhang Li Liu Li-Mei Fan Shi-Shuang Ruan Fen Wang |
| author_sort | Dan Li |
| collection | DOAJ |
| description | Despite the ubiquity of the Boston naming test (BNT) in clinical practice and research, concerns have been expressed about its poor quality pictures, insufficient psychometric properties, and cultural bias in non-English language backgrounds. We modified the black-and-white BNT with a set of color pictures since color effects have been suggested to improve naming accuracy in the visual naming test. This study aimed to examine and compare the reliability and validity of the color-picture version of BNT (CP-BNT) and the black-and-white version of BNT (BW-BNT) to differentiate amnestic mild cognitive impairment (aMCI) or mild Alzheimer's disease (AD) from the cognitive normals. This study included two subgroups, and each subgroup had 101 normal controls, 51 aMCI, and 52 mild AD. One subgroup undertook BW-BNT and the other conducted CP-BNT. The reliability, convergent and discriminant validity, and the diagnostic accuracy of two versions of BNT were evaluated. The CP-BNT showed a greater area under the curve (AUC) than the BW-BNT for aMCI (80.3 vs.s 69.4%) and mild AD (93.5 vs. 77.6%). The CP-BNT also demonstrated better convergent validity with CDR global scores and better reliability (Cronbach's coefficient 0.66 for the CP-BNT vs. 0.55 for the BW-BNT). At the optimal cutoff value of spontaneous naming, the CP-BNT demonstrated improved sensitivity and specificity for differentiating mild AD from NC with a higher positive predictive value, negative predictive value, and lower false-positive rate. Compared with BW-BNT, CP-BNT is a more reliable and valid test to assess cognitive and naming impairment. |
| first_indexed | 2024-12-11T05:32:43Z |
| format | Article |
| id | doaj.art-acb92332f9164dd68a8091532fda25e0 |
| institution | Directory Open Access Journal |
| issn | 1664-2295 |
| language | English |
| last_indexed | 2024-12-11T05:32:43Z |
| publishDate | 2022-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neurology |
| spelling | doaj.art-acb92332f9164dd68a8091532fda25e02022-12-22T01:19:23ZengFrontiers Media S.A.Frontiers in Neurology1664-22952022-04-011310.3389/fneur.2022.884460884460A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's DiseaseDan Li0Yue-Yi Yu1Nan Hu2Min Zhang3Li Liu4Li-Mei Fan5Shi-Shuang Ruan6Fen Wang7Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInnovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, ChinaDiscipline of Pediatrics & Child Health, School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, AustraliaDepartment of Radiology, Xuanwu Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInnovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, ChinaDespite the ubiquity of the Boston naming test (BNT) in clinical practice and research, concerns have been expressed about its poor quality pictures, insufficient psychometric properties, and cultural bias in non-English language backgrounds. We modified the black-and-white BNT with a set of color pictures since color effects have been suggested to improve naming accuracy in the visual naming test. This study aimed to examine and compare the reliability and validity of the color-picture version of BNT (CP-BNT) and the black-and-white version of BNT (BW-BNT) to differentiate amnestic mild cognitive impairment (aMCI) or mild Alzheimer's disease (AD) from the cognitive normals. This study included two subgroups, and each subgroup had 101 normal controls, 51 aMCI, and 52 mild AD. One subgroup undertook BW-BNT and the other conducted CP-BNT. The reliability, convergent and discriminant validity, and the diagnostic accuracy of two versions of BNT were evaluated. The CP-BNT showed a greater area under the curve (AUC) than the BW-BNT for aMCI (80.3 vs.s 69.4%) and mild AD (93.5 vs. 77.6%). The CP-BNT also demonstrated better convergent validity with CDR global scores and better reliability (Cronbach's coefficient 0.66 for the CP-BNT vs. 0.55 for the BW-BNT). At the optimal cutoff value of spontaneous naming, the CP-BNT demonstrated improved sensitivity and specificity for differentiating mild AD from NC with a higher positive predictive value, negative predictive value, and lower false-positive rate. Compared with BW-BNT, CP-BNT is a more reliable and valid test to assess cognitive and naming impairment.https://www.frontiersin.org/articles/10.3389/fneur.2022.884460/fullBoston naming testAlzheimer's diseasemild cognitive impairmentnaming deficitlanguage impairment |
| spellingShingle | Dan Li Yue-Yi Yu Nan Hu Min Zhang Li Liu Li-Mei Fan Shi-Shuang Ruan Fen Wang A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease Frontiers in Neurology Boston naming test Alzheimer's disease mild cognitive impairment naming deficit language impairment |
| title | A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease |
| title_full | A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease |
| title_fullStr | A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease |
| title_full_unstemmed | A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease |
| title_short | A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease |
| title_sort | color picture version of boston naming test outperformed the black and white version in discriminating amnestic mild cognitive impairment and mild alzheimer s disease |
| topic | Boston naming test Alzheimer's disease mild cognitive impairment naming deficit language impairment |
| url | https://www.frontiersin.org/articles/10.3389/fneur.2022.884460/full |
| work_keys_str_mv | AT danli acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT yueyiyu acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT nanhu acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT minzhang acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT liliu acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT limeifan acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT shishuangruan acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT fenwang acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT danli colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT yueyiyu colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT nanhu colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT minzhang colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT liliu colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT limeifan colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT shishuangruan colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease AT fenwang colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease |